Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients

Clalit Health Services

Status: Unknown

Conditions: Cardiomyopathy

Treatments: Device: echocardiography

Study type: Interventional

Funder types: Other

Identifiers

NCT02917395

0538-16-RMC

Details and patient eligibility

About

Population study- patients with obstructive hypertrophic cardiomyopathy that are treated with disopyramide.

Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.

Full description

Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hypertrophic cardiomyopathy that treated with disopyramid

Exclusion criteria

• pregnancy
• pacemaker

Trial design

50 participants in 1 patient group

echo

Experimental group

Description:

Population study- patients with obstructive hypertrophic cardiomyopathy that are treated with disopyramide. Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.

Treatment:

Device: echocardiography